Your browser doesn't support javascript.
loading
Impact of human leukocyte antigen mismatch on outcomes after unrelated bone marrow transplantation in paediatric patients: A retrospective analysis by the JSTCT HLA working group.
Kato, Itaru; Sakaguchi, Hirotoshi; Kato, Shunichi; Sato, Maho; Noguchi, Maiko; Yoshida, Nao; Koh, Katsuyoshi; Koike, Takashi; Yanagimachi, Masakatsu; Kato, Keisuke; Takahashi, Yoshiyuki; Fujita, Naoto; Sato, Atsushi; Hashii, Yoshiko; Tabuchi, Ken; Atsuta, Yoshiko; Morishima, Satoko; Kanda, Junya.
Affiliation
  • Kato I; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sakaguchi H; Children Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Kato S; Department of Innovative Medicine, Division of Stem Cell Transplantation, Tokai University School of Medicine, Isehara, Japan.
  • Sato M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Noguchi M; Department of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Yoshida N; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
  • Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Koike T; Department of Pediatrics, Tokai University School of Medicine, Isehara, Japan.
  • Yanagimachi M; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Kato K; Division of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Ibaraki, Japan.
  • Takahashi Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fujita N; Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Sato A; Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan.
  • Hashii Y; Department of pediatrics, Osaka International Cancer Institute, Osaka, Japan.
  • Tabuchi K; Division of Pediatrics, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Morishima S; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Kanda J; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara-cho, Japan.
Br J Haematol ; 199(3): 392-400, 2022 11.
Article de En | MEDLINE | ID: mdl-36029121
ABSTRACT
The impact of human leukocyte antigen (HLA) mismatching at the HLA-A, -B, -C, and -DRB1 loci after unrelated bone marrow transplantation in paediatric patients with haematological malignancies has not been fully examined. Here, we analysed patients with haematological malignancies (all aged ≤15 years; n = 1330) who underwent a first unrelated bone marrow transplantation between 1993 and 2017 in Japan. The results show that although an HLA mismatch was significantly associated with a low relapse rate, it was also associated with higher non-relapse mortality. There was a significant association between HLA mismatch and low overall survival. Locus mismatch analysis revealed that, as in adults, an HLA-C mismatch had a significant negative impact on survival; however, in paediatric patients, an HLA-DRB1 mismatch did not have a negative impact, although these HLA mismatch effects are weakened in recent cases. Taken together, the results suggest that an HLA-matched donor should be the first candidate for paediatric patients; however, for patients without a matched sibling or matched unrelated donor, we can select an unrelated donor with a mismatch at HLA-DRB1 if available.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs hématologiques / Maladie du greffon contre l'hôte Type d'étude: Observational_studies / Risk_factors_studies Limites: Child / Humans Langue: En Journal: Br J Haematol Année: 2022 Type de document: Article Pays d'affiliation: Japon

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs hématologiques / Maladie du greffon contre l'hôte Type d'étude: Observational_studies / Risk_factors_studies Limites: Child / Humans Langue: En Journal: Br J Haematol Année: 2022 Type de document: Article Pays d'affiliation: Japon
...